Philips Medical Systems Nederland B.V.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. In 2019, Philips invested EUR 1.9 billion in Research and Development, or 10% of sales. Royal Philips’ total IP portfolio currently consists of around 64,500 patent rights, 39,000 trademarks, 88,500 design rights and 3,200 domain names. Philips filed 1,015 new patents in 2019, with a strong focus on the growth areas in health technology services and solutions.
Remote Monitoring in Health and sports
Eco-system for disease specific clinical workflow and data integration
Timeline-Driven Digital Twin
Spectral Analysis in life sciences and materials sciences through Artificial Intelligence
Automation, Surgery Support and Intuitive 3D visualization to optimize workflow in IGT SysTems
Sensing and Image-Guided Neurological therapies, cardiac Electrophysiology and Tumour treatments
Digital Lifecycle Twins for predictive maintenance
Intelligence based iMprovement of Personalized treatment And Clinical workflow supporT
Medical care evolution
Better Effectiveness aNd EFficiency by measuring and modelling of Interventional Therapy
System of Real-Time Systems
Medical Distributed Utilization of Services & Applications
Patient Friendly Medical Intervention